High-dose methotrexate and asparaginase for the treatment of children with acute lymphoblastic leukemia: why and how?

J Pediatr Hematol Oncol. 2004 Jun;26(6):333-5. doi: 10.1097/00043426-200406000-00001.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Asparaginase / therapeutic use*
  • Child
  • Humans
  • Leucovorin / therapeutic use
  • Methotrexate / therapeutic use*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*

Substances

  • Antineoplastic Agents
  • Asparaginase
  • Leucovorin
  • Methotrexate